ArticleAnnals of the New York Academy of Sciences2018

CTLA-4Ig (abatacept) balances bone anabolic effects of T cells and Wnt-10b with antianabolic effects of osteoblastic sclerostin.

Susanne Roser-Page et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.